Both IFNα and IFNβ have anti-dengue activity in cell cultures in vitro and in animal models in vivo. However, previous clinical studies have only examined IFNα levels in the context of either DENV2 or DENV3 infections [10], [11], [21]. This evidence concerns the gene IFNB1 and infection.